Qianqian Zhang Haiyang Liu Jia Yang
10.3389/fendo.2022.833929
Front Endocrinol (Lausanne)
2022 May 23;13:833929.
l858r nsclc aumolertinib cardiac failure osimertinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/35677717/
Carcinoma, Non-Small-Cell Lung / drug therapy Carcinoma, Non-Small-Cell Lung / genetics Heart Failure Lung Neoplasms / drug therapy Lung Neoplasms / genetics Lung Neoplasms / pathology
Carcinoma, Non-Small-Cell Lung / drug therapy Carcinoma, Non-Small-Cell Lung / genetics Heart Failure Lung Neoplasms / drug therapy Lung Neoplasms / genetics Lung Neoplasms / pathology Case Reports Review Acrylamides Aniline Compounds ErbB Receptors / genetics Female Humans Indoles Middle Aged Pyrimidines Acrylamides Aniline Compounds Indoles Pyrimidines osimertinib EGFR protein, human ErbB Receptors aumolertinib
PMC9170288
35677717
Aumolertinib Effectively Reduces Clinical Symptoms of an EGFR L858R-Mutant Non-Small Cell Lung Cancer Case Coupled With Osimertinib-Induced Cardiotoxicity: Case Report and Review
2022